By Editor , 25 September 2026
TIER IV Opens Autoware Simulator to Students at Tokyo's Miraikan

Tokyo – September 24, 2026 -- TIER IV, the developer behind the open-source Autoware autonomous driving platform, will co-host a hands-on AI and autonomous driving education event for junior and senior high school students on September 26 at the National Museum of Emerging Science and Innovation (Miraikan) in Tokyo.

By Editor , 25 September 2026
Cellid Debuts Crux AR Glasses on Snapdragon at Qualcomm Summit

Tokyo – September 24, 2026 -- Cellid Inc. is showcasing its binocular, full-color AR glasses reference design "Crux" at Snapdragon Summit, the annual technology event hosted by Qualcomm Technologies, Inc. in Hawaii, USA, running September 22-24, 2026.

By Editor , 24 September 2026
TIER IV Open-Sources Autonomous Kart Design for 240-Team Challenge

Tokyo – September 24, 2026 -- TIER IV, the developer of the open-source Autoware autonomous driving platform, has released a reference design for autonomous racing kart systems on a public GitHub repository, providing a common technical foundation used by 240 teams and roughly 600 participants in Japan's Autonomous Driving AI Challenge.

By Editor , 24 September 2026
transcosmos Joins KEIZAI DOYUKAI Youth Mentoring Program with SANKAKUSHA

Tokyo – September 24, 2026 -- transcosmos inc. has committed employee mentors to a six-month youth support program run with nonprofit SANKAKUSHA, part of a Collaborative Growth Society initiative led by KEIZAI DOYUKAI, the Japan Association of Corporate Executives.

By Editor , 24 September 2026
Industrious Doubles San Diego Hub to 54,000 Sq Ft on Tech Demand

San Diego – – September 24, 2026 -- Industrious, in partnership with GANMI, is adding roughly 27,000 square feet to its Core Columbia workplace at 401 W A St in downtown San Diego, doubling the footprint to approximately 54,000 square feet. Members will gain access to the expanded space starting June 2027.

By Editor , 24 September 2026
Astellas Doses First Patient in Phase 3 Lung Cancer Trial of Setidegrasib

Tokyo – September 24, 2026 -- Astellas Pharma Inc. (TSE: 4503) has dosed the first patient in a Phase 3 study evaluating setidegrasib, an investigational KRAS G12D-targeted protein degrader, against docetaxel in previously treated non-small cell lung cancer (NSCLC) patients carrying the KRAS G12D mutation.

By Editor , 21 September 2026
Axcelis to Showcase SiC Implantation Tech at ICSCRM 2026 in Japan

Beverly, Mass. – September 21, 2026 -- Axcelis Technologies (NASDAQ: ACLS) will exhibit at the 23rd International Conference on Silicon Carbide and Related Materials (ICSCRM 2026), targeting a silicon carbide device market Yole Group projects to reach $11 billion by 2031, expanding at a 20% compound annual growth rate from 2025 to 2031.

By Editor , 21 September 2026
FDA Grants Priority Review to Insmed's ARIKAYCE Full Approval Bid

Bridgewater, N.J. – September 21, 2026 -- The U.S. Food and Drug Administration has accepted Insmed Incorporated's supplemental New Drug Application (sNDA) for full approval of ARIKAYCE (amikacin liposome inhalation suspension) to treat Mycobacterium avium complex (MAC) lung disease, granting Priority Review with a PDUFA target action date of January 28, 2027.